Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …

Background: Abdominal aortic aneurysm (AAA), a progressive segmental abdominal aortic
dilation, is associated with high mortality. AAA is characterized by inflammation, smooth …

Background: Aortic aneurysm (AA) is a “silent killer” human disease with no effective
treatment. Although the therapeutic potential of various pharmacological agents have been …

Background Abdominal aortic aneurysms (AAA) rupture can lead to patient death. Surgical
treatment is currently the optimal treatment for AAA with large diameter (≥ 50 mm). For AAA …

Objective Large abdominal aortic aneurysms (AAAs) present a significant mortality risk.
While numerous medical interventions have been proposed, no drugs have convincingly …

Objective The objective of this study was to summarize the literature regarding the effects of
renin-angiotensin system blockade (RASB) using angiotensin-converting enzyme inhibitors …

Background The best medical therapy to control hypertension following abdominal aortic
aneurysm repair is yet to be determined. We therefore examined whether treatment with …

Objective Whether angiotensin II blockade is an effective medical treatment for abdominal
aortic aneurysms (AAAs) has not been established. This systematic review and meta …

Acute aortic syndrome is a group of interlinked conditions with common presenting
symptoms, including aortic dissection, penetrating atherosclerotic ulcer, and intramural …

El aneurisma aórtico abdominal (AAA) es una dilatación progresiva localizada en la aorta
abdominal, que se asocia a una elevada tasa de mortalidad. Su fisiopatología es compleja …